policy
Guidelines for use of exempt biologics
State-licensed veterinarians may consider preparing biologics in their practice facility under a VCPR in unique disease situations not adequately…
JAVMA news
The slow rise of generic animal drugs
In human medicine, generic drugs accounted for 88 percent of prescriptions dispensed in the United States as of 2014.
JAVMA news
Editing Animals
Recent gene-editing technologies are being used to create mice that model human genetic diseases, Holstein cattle lacking horns, and current research…
JAVMA news
Pig drug may be withdrawn over residues
Food and Drug Administration officials are working to rescind approval of a swine-use drug that may leave carcinogenic residues in pork.
JAVMA news
Q&A with Dr. Elizabeth A. Curry-Galvin
Dr. Elizabeth A. Curry-Galvin, outgoing deputy chief executive officer of the AVMA, answers questions from JAVMA News.
JAVMA news
Old, new deputy CEO see AVMA moving profession forward
What kept Dr. Elizabeth A. Curry-Galvin on the staff of the AVMA for two decades?
Committee on Antimicrobials
The Committee on Antimicrobials supports AVMA’s strategy to allow the veterinary profession to effectively share robust and comprehensive…
JAVMA news
AVMA advocates against prescription mandate bill
In April, AVMA Board of Directors chair Dr. John de Jong testified before a House subcommittee about the Fairness to Pet Owners Act (HR 3174/S 1200),
JAVMA news
Back to Basics
Veterinarians today are able to provide better and more advanced medical care for pets than ever before, but the cost of that care makes it out of…